The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Therapeutic Peptides in Aesthetic, Metabolic and Endocrine Conditions: Effects, Safety, Clinical Applications, and Future Perspectives RFK Jr. promotes peptides. Now the FDA weighs easing limits on the unproven chemicals of the Federal Food, Drug, and Cosmetic Act (FDCA).* FDA Is Expected to Lift Restriction on Peptides, Heeding RFK Jr.'s Wishes The New York Times